2021 IPO

Miromatrix Medical Stock

Biological human organ development

Sign up today and learn more about Miromatrix Medical Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

National Institute of Diabetes and Digestive and Kidney Diseases


Eden Prairie MN, US

Total Funding


About Miromatrix Medical Stock

Miromatrix Medical is a biotechnology company engaged in the development of fully biological human organs and organ-derived biological products to solve the chronic shortage of transplantable organs, utilizing its patented perfusion decellularization or recellularization technology, as well as organ-derived biological products for applications such as soft tissue reinforcement and advanced wound care. The company was founded in 2009 and is based in Eden Prairie, Minnesota.


Brightstone Venture Capital

Miromatrix Medical

National Institute of Diabetes and Digestive and Kidney Diseases

Miromatrix Medical

Funding History

December 2011$2.0M
July 2012$5.3M
October 2013$5.0M
May 2014$6.1M
August 2015$23.3M
July 2018$15.7M
November 2019$2.0M


President and CEO

Jeff Ross, Ph.D

Vice-President of Research and Development

Thomas Gilbert, Ph.D


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: